Intermittent Claudication: Pharmacoeconomic and Quality-of-Life Aspects of Treatment

Author： Brevetti G.   Annecchini R.   Bucur R.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.20, Iss.3, 2002-01, pp. : 169-181

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Options in the Treatment of Multiple Myeloma: Pharmacoeconomic and Quality-of-Life Considerations

By Wisløff F.  

PharmacoEconomics, Vol. 16, Iss. 4, 1999-10 ,pp. : 329-341

Adis International

Access to resources Recommend Favorite

International Validation of the CLAU-S Quality-of-Life Questionnaire for Use in Patients with Intermittent Claudication

By Marquis P.  

PharmacoEconomics, Vol. 19, Iss. 6, 2001-06 ,pp. : 667-677

Adis International

Access to resources Recommend Favorite

Naftidrofuryl: A Review of its Use in the Treatment of Intermittent Claudication

By Goldsmith David R.   Wellington Keri  

Drugs & Aging, Vol. 22, Iss. 11, 2005-01 ,pp. : 967-977

Adis International

Access to resources Recommend Favorite

Intermittent Claudication in Older Patients: Practical Treatment Guidelines

By Boccalon H.  

Drugs & Aging, Vol. 14, Iss. 4, 1999-04 ,pp. : 247-259

Adis International

Access to resources Recommend Favorite

Global Registries for Measuring Pharmacoeconomic and Quality-of-Life Outcomes: Focus on Design and Data Collection, Analysis and Interpretation

By Kennedy L.   Craig A-M.  

PharmacoEconomics, Vol. 22, Iss. 9, 2004-01 ,pp. : 551-568

Adis International

Access to resources Recommend Favorite